Mirae Asset Global Investments’s Meridian Bioscience Inc VIVO Stock Holding History

Mirae Asset Global Investments’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-19,106	Closed	-$635K	–	2628
2022 Q4	$635K	Hold	19,106	–	–	﹤0.01%	1752
2022 Q3	$602K	Buy	19,106 +5,163	+37%	+$167K	﹤0.01%	1763
2022 Q2	$424K	Buy	+13,943	New	+$377K	﹤0.01%	1836

Other funds holding VIVO

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Mirae Asset Global Investments's VIVO Position: Q1 2023 in Review

Mirae Asset Global Investments sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 19,106 shares — an estimated $635K sold.

Mirae Asset Global Investments first reported a position in VIVO in Q2 2022 and held it in 3 quarters. The position peaked at $635K in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

Mirae Asset Global Investments reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
Mirae Asset Global Investments sold 19,106 Meridian Bioscience Inc shares in Q1 2023, an estimated $635K.
Mirae Asset Global Investments first reported a position in Meridian Bioscience Inc in Q2 2022 and held it in 3 quarters.
Mirae Asset Global Investments's Meridian Bioscience Inc position peaked at $635K in Q4 2022.
2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on Mirae Asset Global Investments's 13F filing for Q1 2023, filed 4 May 2023.